ML
NVRO

McAdam LLC’s NEVRO CORP. NVRO Stock Holding History

McAdam LLC’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-18
Closed -$2K – 838
2018
Q1 		$2K Buy
+18
New +$1.45K ﹤0.01% 582

Other funds holding NVRO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

McAdam LLC's NVRO Position: Q2 2018 in Review

McAdam LLC sold out of NEVRO CORP. (NVRO) in Q2 2018, closing a stake of 18 shares — an estimated $2K sold.

McAdam LLC first reported a position in NVRO in Q1 2018 and held it in 1 quarter. The position peaked at $2K in Q1 2018. 192 funds tracked by Wall St. Rank hold NVRO as of Q2 2018.

  • McAdam LLC reported no remaining NEVRO CORP. position as of Q2 2018 after selling out during the quarter.
  • McAdam LLC sold 18 NEVRO CORP. shares in Q2 2018, an estimated $2K.
  • McAdam LLC first reported a position in NEVRO CORP. in Q1 2018 and held it in 1 quarter.
  • McAdam LLC's NEVRO CORP. position peaked at $2K in Q1 2018.
  • 192 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2018.

Based on McAdam LLC's 13F filing for Q2 2018, filed 22 Aug 2018.